News

KESQ35m
Living Healthy: HIV clinics brace for uncertainty as Congress weighs spending bill, medicaid cuts
As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...
Aliveness Project to offer newly approved, first-of-its-kind HIV prevention treatment
The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...
Federal funding halt threatens HIV and STI testing in Corpus Christi
While a Coastal Bend organization's free HIV testing will likely end July 1 due to a grant pause, the health district promises to continue services.
WFYI1d
Trump's policies could undermine the fight to end America's HIV epidemic
The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...
NIH office to phase out HIV guidelines by next year
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
Administration to phase out NIH support of HIV clinical guidelines
The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.
The FDA Just Approved a Long-Lasting Injection to Prevent HIV
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
ABS-CBN on MSN4d
US approves Gilead's twice-yearly injection to prevent HIV
The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV, a move the ...
The FDA Approves Powerful HIV Prevention Drug
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
Opinion
Bulletin of the Atomic Scientists7dOpinion
The consequences of the Trump administration’s hostile empathy
A former intelligence officer's 1980 reflections on selecting Cold War targets are worth revisiting in the wake of the second Trump administration, but perhaps not for the reasons you might imagine.